Medicine and Dentistry
Woman
100%
Polycystic Ovary Syndrome
50%
Patient
44%
Stimulation
31%
Pregnancy
26%
Pregnancy Rate
25%
Hirsutism
22%
Emergency Contraception
21%
Follicular Phase
19%
Letrozole
19%
Obese Woman
19%
Gonadorelin Antagonist
19%
Randomized Clinical Trial
17%
Metabolic Syndrome
16%
Menstrual Cycle
16%
Oocyte
16%
Insulin Resistance
15%
Follitropin
15%
Emergency
14%
Fertility Preservation
14%
Reproductive Medicine
13%
Randomized Controlled Trial
12%
Sexual Intercourse
11%
Glucose
11%
Therapeutic Procedure
11%
Insulin Sensitizing Agent
11%
Estradiol
10%
Sperm
10%
Analysis
10%
Hyperinsulinism
10%
Ethinylestradiol
9%
Levonorgestrel
9%
Meta-Analysis
9%
Birth Rate
9%
Controlled Ovarian Hyperstimulation
9%
Gestational Diabetes
9%
Glycon
9%
Testosterone
8%
Glucose Metabolism
8%
Retrospective Study
8%
Androgen
8%
Assisted Reproduction
7%
Condom
7%
Exercise
6%
Spermatozoon
6%
Ovarian Hyperstimulation Syndrome
6%
Diet
6%
Childbirth
6%
Spontaneous Abortion
6%
Quantitative Insulin Sensitivity Check Index
6%
Nursing and Health Professions
Woman
52%
Patient
20%
Hirsutism
19%
Ovary Polycystic Disease
17%
Clinician
14%
Pregnancy Rate
14%
Analysis
12%
Control
12%
Procedures
11%
Urine Incontinence
9%
Live Birth
9%
Birth Rate
9%
Body Weight Loss
9%
Confidence Interval
9%
Pilot Study
6%
Ethinylestradiol
6%
Consultation
6%
Testosterone
5%
Follow up
5%
Biochemistry, Genetics and Molecular Biology
Pregnancy
37%
Prolactin
30%
Follicular Phase
19%
Letrozole
19%
Reproduction
16%
Follicle-Stimulating Hormone
15%
Dose
15%
Sexual Intercourse
11%
Insulin
11%
Prospective Study
9%
Taxonomy
8%
Glucose Metabolism
8%
Metoclopramide
8%
Pregnancy Rate
6%
Birth
6%
Insulin Sensitivity
5%
Macroprolactin
5%
Menstrual Cycle
5%
